We are monitoring the impact of COVID-19 on Europe Human Microbiome Market Get in touch with us for detailed analysis Know More
Pulished Date November, 2021
ID: 12391
Share on
Share on

Europe Human Microbiome Market Research Report - Segmented By Product, Application, Disease Type & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU) – Industry Forecast (2021 to 2026)

Pulished: November, 2021
ID: 12391
Pages: 100

Europe Human Microbiome Market Size (2021 to 2026)

The size of the human microbiome market in the European region is forecasted to be worth USD 723.08 million by 2026 from USD 273.32 million in 2021, growing at a CAGR of 21.48% from 2021 to 2026.

Factors such as the continued trend of self-cleaning technologies in many end-user industries, increasing prevalence of chronic lifestyle diseases and microbial dysbiosis infections, increased use of plastic and paper as packaging materials, and the growth of the senior population, which is more susceptible to microbial diseases, are expected to drive the development of the Europe human microbiome market. Human microbiomes find their use self-cleanse fabric, antimicrobial coatings for hospital infections, polycarbonate substrate, etc. On average, approximately 5.8% of patients acquired an infection across EU countries during their hospital stay in 2017-18. The percentage observed was lowest in Bulgaria, Germany, Latvia, the Netherlands, and Romania, recoding at less than 4%. In contrast, the highest infection rate was observed in Greece, Italy, Finland, and Cyprus at over 8%.

The market's growth can also be attributed to the increasing focus on developing more effective human microbiome therapies. For example, human gut microbiomes are developed in specific combinations as treatment modalities for various gastrointestinal conditions such as Irritable bowel syndrome, Gastrointestinal reflux syndrome, Crohn's disease, etc. Irritable bowel syndrome affects around 10-15% of the European population. These numbers are anticipated to increase owing to lifestyle stress, unhealthy diet, drug and alcohol abuse, and increased use of GMOs in food items. In addition, human microbiomes help study the severity of infections and develop appropriate therapies and vaccines. Factors such as infection, inflammation, diet, xenobiotics, hygiene, and altered host genetics can cause an imbalance in the gut microflora. Therefore, efforts are underway to design interventions to modulate the microbiome to improve human health. These targeted microbiome-based therapies are also driving the growth of the market. However, other factors, including extensive research and development activities and significant growth in the pharmaceutical industry, are expected to drive the market growth.

However, strict government guidelines, the high cost of microbiome therapy, lack of reimbursement policies, concerns about the effectiveness of the microbiome-based therapies, and a lack of detailed control and knowledge are likely to impact the market's growth for years to come negatively. For example, according to the International Agency for Research on Cancer, the inhalable powder of human microbiome mixture containing titanium oxide is regarded as a carcinogen because of its potential to induce lung cancer due to inhalation. This, in turn, is expected to dampen the growth of the European human microbiome market.

This research report on the European human microbiome market has been segmented and sub-segmented into the following categories.

By Disease:

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
  • Infectious disease

By Product:

  • Probiotic
  • Foods
  • Medical Foods
  • Diagnostic Device
  • Drugs
  • Supplements

By Application:

  • Therapeutics
  • Diagnostics

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the German market is expected to dominate the European human microbiome market during the forecast period, owing to the increasing incidence rate of various gastrointestinal disorders, a significant investment for studying about human microbiome for research and development, and the increased awareness of probiotics for their role in preventive health and in balancing the gut microbiome. Furthermore, according to an article published by the Centers for Disease Control and Prevention, 2019, Clostridium difficile infection is one of the most common nosocomial infections globally, resulting in more than 50,000 deaths annually.

The United Kingdom is expected to experience significant growth in the European human microbiome market, owing to the increase in research and development activities of market players and increased healthcare awareness in the population. As a result, the probiotics market in the United Kingdom is expected to register a CAGR of 5.6%. As a result, demand for probiotics in the UK is expected to grow the fastest in Europe. This growing demand is set to grab the attention of international key players, which will provide many growth opportunities in the UK and other European regions.

KEY MARKET PLAYERS:

Microbiotica, Rebiotix, Inc., Locus Biosciences, Second Genome Inc., Osel Inc., Second Genome, Kallyope, Finch Therapeutics, Concentric, Synthetic Biologics, Inc., DuPont, BiomX Ltd, MaaT Pharma, Eligo Bioscience, SNIPR Biome, Ritter Pharmaceuticals, DayTwo, Yeda Research and Development Co. Ltd., MyBiome, AOBiome, Enterome, Yakult Honsha Co., Ltd., MicroBiome Therapeutics LLC, and Metabiomics Corporate are companies playing a leading role in the European human microbiome market.

  1. Introduction                                 
    1. Market Definition                    
    2. Scope of the report                 
    3. Study Assumptions                 
    4. Base Currency, Base Year and Forecast Periods                           
  2. Research Methodology                                           
    1. Analysis Design                         
    2. Research Phases                      
      1. Secondary Research           
      2. Primary Research 
      3. Data Modelling     
      4. Expert Validation  
    3. Study Timeline                          
  3. Report Overview                                        
    1. Executive Summary                
    2. Key Inferences                       
  4. Market Dynamics                                       
    1. Impact Analysis                        
      1. Drivers      
      2. Restraints 
      3. Opportunities        
    2. Regulatory Environment                       
    3. Technology Timeline & Recent Trends                            
  5. Competitor Benchmarking Analysis                                    
    1. Key Player Benchmarking                     
      1. Market share analysis         
      2. Products/Service 
      3. Regional Presence
    2. Mergers & Acquisition Landscape                      
    3. Joint Ventures & Collaborations                        
  6. Market Segmentation                                              
    1. Global Human Microbiome Market, By Disease
      1. Obesity
      2. Diabetes
      3. Autoimmune Disorders
      4. Cancer
      5. Mental Disorders
      6. Infectious disease
      7. Market Size Estimations & Forecasts (2021-2026)   
      8. Y-o-Y Growth Rate Analysis              
      9. Market Attractiveness Index           
    2. Global Human Microbiome Market, By Product
      1. Probiotic
      2. Foods
      3. Medical Foods
      4. Diagnostic Device
      5. Drugs
      6. Supplements
      7. Market Size Estimations & Forecasts (2021-2026)   
      8. Y-o-Y Growth Rate Analysis              
      9. Market Attractiveness Index         
    3. Global Human Microbiome Market, By Application
      1. Therapeutics
      2. Diagnostics
      3. Market Size Estimations & Forecasts (2021-2026)   
      4. Y-o-Y Growth Rate Analysis              
      5. Market Attractiveness Index         
  7. Geographical Landscape                                         
    1. Europe                         
      1. By Country              
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
  8. Key Player Analysis                                    
    1. Cooper vision
      1. Business Description           
      2. Products/Service 
      3. Financials 
      4. SWOT Analysis      
      5. Recent Developments       
      6. Analyst Overview 
    2. Microbiotica
    3. Rebiotix, Inc
    4. Locus Biosciences
    5. Second Genome Inc.
    6. Osel Inc.
    7. Second Genome
    8. Kallyope
    9. Finch Therapeutics
    10. Concentric
    11. Synthetic Biologics, Inc.
    12. DuPont, BiomX Ltd
    13. MaaT Pharma
    14. Eligo Bioscience
    15. SNIPR Biome
    16. Ritter Pharmaceuticals
    17. DayTwo
    18. Yeda Research and Development Co. Ltd
    19. MyBiome
    20. AOBiome
    21. Enterome
    22. Yakult Honsha Co., Ltd
    23. MicroBiome Therapeutics LLC
    24. Metabiomics Corporate
  9. Market Outlook & Investment Opportunities
    1. Appendix
      1. List of Tables
      2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of disease, product and application along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  2. Europe Obesity Market, By Region, From 2021 to 2026 (USD Billion)
  3. Europe Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Autoimmune Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  6. Europe Mental Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Infectious disease Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  9. Europe  Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  12. Europe Probiotic Market, By Region, From 2021 to 2026 (USD Billion)
  13. Europe  Foods Market, By Region, From 2021 to 2026 (USD Billion)
  14. Europe Medical Foods Market, By Region, From 2021 to 2026 (USD Billion)
  15. Europe Diagnostic Device Market, By Region, From 2021 to 2026 (USD Billion)
  16. Europe Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  17. Europe Supplements Market, By Region, From 2021 to 2026 (USD Billion)
  18. U.K. Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  19. U.K. Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  20. U.K. Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  21. Germany Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  22. Germany Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  23. Germany Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  24. France Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  25. France Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  26. France Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  27. Italy Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  28. Italy Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  29. Italy Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)
  30. Spain Human Microbiome Market, By Disease, From 2021 to 2026 (USD Billion)
  31. Spain Human Microbiome Market, By Application, From 2021 to 2026 (USD Billion)
  32. Spain Human Microbiome Market, By Product, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample